Continuation of Antiarrhythmics Following Ventricular Tachycardia Catheter Ablation
Status:
Recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
The investigators aim to study if patients that undergo catheter ablation for ventricular
tachycardia benefit from continuation of Vaughan-Williams class III antiarrhythmic drugs for
3 months after their ablation.